{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T09:05:51Z","timestamp":1790845551897,"version":"4.1.0"},"reference-count":100,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,1,9]],"date-time":"2019-01-09T00:00:00Z","timestamp":1546992000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infectious Disease Clinics of North America"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.idc.2018.10.002","type":"journal-article","created":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T02:49:47Z","timestamp":1548989387000},"page":"39-60","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":84,"title":["Malaria"],"prefix":"10.1016","volume":"33","author":[{"given":"Katherine","family":"Plewes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stije J.","family":"Leopold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugh W.F.","family":"Kingston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjen M.","family":"Dondorp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.idc.2018.10.002_bib1","series-title":"World malaria report 2017","author":"World Health Organization","year":"2017"},{"key":"10.1016\/j.idc.2018.10.002_bib2","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1093\/4.4.908","article-title":"Classics in infectious diseases: a newly discovered parasite in the blood of patients suffering from malaria. Parasitic etiology of attacks of malaria: Charles Louis Alphonse Laveran (1845-1922)","volume":"4","author":"Laveran","year":"1982","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.idc.2018.10.002_bib3","doi-asserted-by":"crossref","first-page":"e1038","DOI":"10.1016\/S2214-109X(17)30333-9","article-title":"Outbreak of human malaria caused by Plasmodium simium in the Atlantic Forest in Rio de Janeiro: a molecular epidemiological investigation","volume":"5","author":"Brasil","year":"2017","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.idc.2018.10.002_bib4","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/1475-2875-13-68","article-title":"First case of a naturally acquired human infection with Plasmodium cynomolgi","volume":"13","author":"Ta","year":"2014","journal-title":"Malar J"},{"key":"10.1016\/j.idc.2018.10.002_bib5","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/B978-0-12-397900-1.00003-7","article-title":"Plasmodium vivax: clinical spectrum, risk factors and pathogenesis","volume":"80","author":"Anstey","year":"2012","journal-title":"Adv Parasitol"},{"key":"10.1016\/j.idc.2018.10.002_bib6","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1093\/cid\/cis902","article-title":"A\u00a0prospective comparative study of knowlesi, falciparum, and vivax malaria in Sabah, Malaysia: high proportion with severe disease from Plasmodium knowlesi and Plasmodium vivax but no mortality with early referral and artesunate therapy","volume":"56","author":"Barber","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2018.10.002_bib7","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/0035-9203(95)90496-4","article-title":"Intraleucocytic malaria pigment and prognosis in severe malaria","volume":"89","author":"Nguyen","year":"1995","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.idc.2018.10.002_bib8","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/0035-9203(93)90028-O","article-title":"Relation of the stage of parasite development in the peripheral blood to prognosis in severe falciparum malaria","volume":"87","author":"Silamut","year":"1993","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.idc.2018.10.002_bib9","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/0035-9203(89)90322-2","article-title":"Treatment of malaria: some considerations and limitations of the current methods of assessment","volume":"83","author":"White","year":"1989","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.idc.2018.10.002_bib10","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s12936-018-2268-7","article-title":"Performance of an ultra-sensitive Plasmodium falciparum HRP2-based rapid diagnostic test with recombinant HRP2, culture parasites, and archived whole blood samples","volume":"17","author":"Das","year":"2018","journal-title":"Malar J"},{"key":"10.1016\/j.idc.2018.10.002_bib11","doi-asserted-by":"crossref","first-page":"462","DOI":"10.3201\/eid2403.171723","article-title":"Major threat to malaria control programs by Plasmodium falciparum lacking histidine-rich protein 2, Eritrea","volume":"24","author":"Berhane","year":"2018","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.idc.2018.10.002_bib12","doi-asserted-by":"crossref","first-page":"14718","DOI":"10.1038\/s41598-017-15031-2","article-title":"Plasmodium falciparum parasites with histidine-rich protein 2 (pfhrp2) and pfhrp3 gene deletions in two endemic regions of Kenya","volume":"7","author":"Beshir","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.idc.2018.10.002_bib13","series-title":"False-negative RDT results and implications of new reports of P.\u00a0falciparum histidine-rich protein 2\/3 gene deletions","author":"Global Malaria Programme","year":"2017"},{"key":"10.1016\/j.idc.2018.10.002_bib14","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/1475-2875-10-166","article-title":"Prozone in malaria rapid diagnostics tests: how many cases are missed?","volume":"10","author":"Gillet","year":"2011","journal-title":"Malar J"},{"key":"10.1016\/j.idc.2018.10.002_bib15","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.pt.2018.02.006","article-title":"Plasmodium vivax infections of duffy-negative erythrocytes: historically undetected or a recent adaptation?","volume":"34","author":"Gunalan","year":"2018","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.idc.2018.10.002_bib16","doi-asserted-by":"crossref","first-page":"e13236","DOI":"10.1371\/journal.pone.0013236","article-title":"Severe imported falciparum malaria: a cohort study in 400 critically ill adults","volume":"5","author":"Bruneel","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.idc.2018.10.002_bib17","unstructured":"World Health Organization. World Health Organization Guidelines for the treatment of malaria. Third edition. 2015. Available at: http:\/\/www.who.int\/malaria\/publications\/atoz\/9789241549127\/en\/. Accessed May 7, 2016."},{"key":"10.1016\/j.idc.2018.10.002_bib18","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1086\/589287","article-title":"The relationship between age and the manifestations of and mortality associated with severe malaria","volume":"47","author":"Dondorp","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2018.10.002_bib19","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s12916-017-0906-5","article-title":"Clinical and laboratory predictors of death in African children with features of severe malaria: a systematic review and meta-analysis","volume":"15","author":"Sypniewska","year":"2017","journal-title":"BMC Med"},{"key":"10.1016\/j.idc.2018.10.002_bib20","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1093\/cid\/cis034","article-title":"Predicting the clinical outcome of severe falciparum malaria in African children: findings from a large randomized trial","volume":"54","author":"von Seidlein","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2018.10.002_bib21","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1086\/605439","article-title":"Clinical and laboratory features of human Plasmodium knowlesi infection","volume":"49","author":"Daneshvar","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2018.10.002_bib22","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.3201\/eid.1707.101017","article-title":"Severe Plasmodium knowlesi malaria in a tertiary care hospital, Sabah, Malaysia","volume":"17","author":"William","year":"2011","journal-title":"Emerg Infect Dis"},{"issue":"Suppl\u00a01","key":"10.1016\/j.idc.2018.10.002_bib23","first-page":"7","article-title":"Severe malaria","volume":"19","author":"World Health Organization","year":"2014","journal-title":"Trop Med Int Health"},{"key":"10.1016\/j.idc.2018.10.002_bib24","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0140-6736(05)67176-0","article-title":"SEAQUAMAT Trial Group. Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial","volume":"366","author":"Dondorp","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.idc.2018.10.002_bib25","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1016\/S0140-6736(10)61924-1","article-title":"Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial","volume":"376","author":"Dondorp","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.idc.2018.10.002_bib26","doi-asserted-by":"crossref","first-page":"e444","DOI":"10.1371\/journal.pmed.0030444","article-title":"Population pharmacokinetics of artesunate and dihydroartemisinin following intra-rectal dosing of artesunate in malaria patients","volume":"3","author":"Simpson","year":"2006","journal-title":"PLoS Med"},{"key":"10.1016\/j.idc.2018.10.002_bib27","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1006\/expr.1993.1010","article-title":"Plasmodium falciparum: in\u00a0vitro studies of the pharmacodynamic properties of drugs used for the treatment of severe malaria","volume":"76","author":"ter Kuile","year":"1993","journal-title":"Exp Parasitol"},{"key":"10.1016\/j.idc.2018.10.002_bib28","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1093\/infdis\/173.3.691","article-title":"Antimalarial drugs reduce cytoadherence and rosetting Plasmodium falciparum","volume":"173","author":"Udomsangpetch","year":"1996","journal-title":"J\u00a0Infect Dis"},{"issue":"9","key":"10.1016\/j.idc.2018.10.002_bib29","article-title":"Artemether for severe malaria","author":"Esu","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.idc.2018.10.002_bib30","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0140-6736(08)61734-1","article-title":"Pre-referral rectal artesunate to prevent death and disability in severe malaria: a placebo-controlled trial","volume":"373","author":"Gomes","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.idc.2018.10.002_bib31","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1212\/WNL.0000000000003372","article-title":"Safety of lumbar puncture in comatose children with clinical features of cerebral malaria","volume":"87","author":"Moxon","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.idc.2018.10.002_bib32","doi-asserted-by":"crossref","first-page":"790","DOI":"10.4269\/ajtmh.2006.75.790","article-title":"Malarial retinopathy: a newly established diagnostic sign in severe malaria","volume":"75","author":"Beare","year":"2006","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.idc.2018.10.002_bib33","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.trstmh.2009.03.001","article-title":"The spectrum of retinopathy in adults with Plasmodium falciparum malaria","volume":"103","author":"Maude","year":"2009","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.idc.2018.10.002_bib34","doi-asserted-by":"crossref","first-page":"e27273","DOI":"10.1371\/journal.pone.0027273","article-title":"Timing of enteral feeding in cerebral malaria in resource-poor settings: a randomized trial","volume":"6","author":"Maude","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.idc.2018.10.002_bib35","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/1475-2875-6-138","article-title":"Mannitol as adjunct therapy for childhood cerebral malaria in Uganda: a randomized clinical trial","volume":"6","author":"Namutangula","year":"2007","journal-title":"Malar J"},{"key":"10.1016\/j.idc.2018.10.002_bib36","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/cid\/cir405","article-title":"Brain swelling and mannitol therapy in adult cerebral malaria: a randomized trial","volume":"53","author":"Mohanty","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2018.10.002_bib37","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1056\/NEJM198202113060601","article-title":"Dexamethasone proves deleterious in cerebral malaria. A double-blind trial in 100 comatose patients","volume":"306","author":"Warrell","year":"1982","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.idc.2018.10.002_bib38","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/infdis\/158.2.325","article-title":"High-dose dexamethasone in quinine-treated patients with cerebral malaria: a double-blind, placebo-controlled trial","volume":"158","author":"Hoffman","year":"1988","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.idc.2018.10.002_bib39","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1177\/1359105307076230","article-title":"Assessing developmental outcomes in children from Kilifi, Kenya, following prophylaxis for seizures in cerebral malaria","volume":"12","author":"Abubakar","year":"2007","journal-title":"J\u00a0Health Psychol"},{"key":"10.1016\/j.idc.2018.10.002_bib40","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0140-6736(99)07148-2","article-title":"Effect of phenobarbital on seizure frequency and mortality in childhood cerebral malaria: a randomised, controlled intervention study","volume":"355","author":"Crawley","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.idc.2018.10.002_bib41","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.jcrc.2013.09.001","article-title":"Fosphenytoin for seizure prevention in childhood coma in Africa: a randomized clinical trial","volume":"28","author":"Gwer","year":"2013","journal-title":"J\u00a0Crit Care"},{"key":"10.1016\/j.idc.2018.10.002_bib42","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1097\/CCM.0b013e31827466d2","article-title":"Fluid resuscitation of adults with severe falciparum malaria: effects on acid-base status, renal function, and extravascular lung water","volume":"41","author":"Hanson","year":"2013","journal-title":"Crit Care Med"},{"key":"10.1016\/j.idc.2018.10.002_bib43","doi-asserted-by":"crossref","first-page":"e25523","DOI":"10.1371\/journal.pone.0025523","article-title":"A\u00a0retrospective analysis of the haemodynamic and metabolic effects of fluid resuscitation in Vietnamese adults with severe falciparum malaria","volume":"6","author":"Nguyen","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.idc.2018.10.002_bib44","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1186\/1475-2875-12-348","article-title":"The reliability of the physical examination to guide fluid therapy in adults with severe falciparum malaria: an observational study","volume":"12","author":"Hanson","year":"2013","journal-title":"Malar J"},{"key":"10.1016\/j.idc.2018.10.002_bib45","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1056\/NEJMoa1101549","article-title":"Mortality after fluid bolus in African children with severe infection","volume":"364","author":"Maitland","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.idc.2018.10.002_bib46","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/1741-7015-11-68","article-title":"Exploring mechanisms of excess mortality with early fluid resuscitation: insights from the FEAST trial","volume":"11","author":"Maitland","year":"2013","journal-title":"BMC Med"},{"key":"10.1016\/j.idc.2018.10.002_bib47","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1741-7015-12-31","article-title":"Invasive bacterial co-infection in African children with Plasmodium falciparum malaria: a systematic review","volume":"12","author":"Church","year":"2014","journal-title":"BMC Med"},{"key":"10.1016\/j.idc.2018.10.002_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ofid\/ofw028","article-title":"High frequency of clinically significant bacteremia in adults hospitalized with falciparum malaria","volume":"3","author":"Nyein","year":"2016","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.idc.2018.10.002_bib49","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/S0140-6736(11)60888-X","article-title":"Relation between falciparum malaria and bacteraemia in Kenyan children: a population-based, case-control study and a longitudinal study","volume":"378","author":"Scott","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.idc.2018.10.002_bib50","doi-asserted-by":"crossref","first-page":"5336","DOI":"10.4049\/jimmunol.1201028","article-title":"Prolonged neutrophil dysfunction after Plasmodium falciparum malaria is related to hemolysis and heme oxygenase-1 induction","volume":"189","author":"Cunnington","year":"2012","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.idc.2018.10.002_bib51","doi-asserted-by":"crossref","first-page":"4946","DOI":"10.1182\/blood-2011-05-353920","article-title":"Digestive vacuoles of Plasmodium falciparum are selectively phagocytosed by and impair killing function of polymorphonuclear leukocytes","volume":"118","author":"Dasari","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.idc.2018.10.002_bib52","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1186\/s13054-015-1023-5","article-title":"The role of previously unmeasured organic acids in the pathogenesis of severe malaria","volume":"19","author":"Herdman","year":"2015","journal-title":"Crit Care"},{"issue":"4","key":"10.1016\/j.idc.2018.10.002_bib53","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000567.pub3","article-title":"Colloids versus crystalloids for fluid resuscitation in critically ill patients","author":"Perel","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.idc.2018.10.002_bib54","doi-asserted-by":"crossref","first-page":"e0143062","DOI":"10.1371\/journal.pone.0143062","article-title":"The safety of a conservative fluid replacement strategy in adults hospitalised with malaria","volume":"10","author":"Aung","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.idc.2018.10.002_bib55","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0140-6736(96)09096-4","article-title":"The effects of dopamine and adrenaline infusions on acid-base balance and systemic haemodynamics in severe infection","volume":"348","author":"Day","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.idc.2018.10.002_bib56","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1186\/1475-2875-13-481","article-title":"Severe vivax malaria: a systematic review and meta-analysis of clinical studies since 1900","volume":"13","author":"Rahimi","year":"2014","journal-title":"Malar J"},{"key":"10.1016\/j.idc.2018.10.002_bib57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ofid\/ofw046","article-title":"Acute kidney injury is common in pediatric severe malaria and is associated with increased mortality","volume":"3","author":"Conroy","year":"2016","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.idc.2018.10.002_bib58","first-page":"1","article-title":"KDIGO clinical practice guideline for acute kidney injury","volume":"2","year":"2012","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.idc.2018.10.002_bib59","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1111\/j.1365-3156.2007.01881.x","article-title":"A\u00a0quantitative ultrastructural study of renal pathology in fatal Plasmodium falciparum malaria","volume":"12","author":"Nguansangiam","year":"2007","journal-title":"Trop Med Int Health"},{"key":"10.1016\/j.idc.2018.10.002_bib60","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/1475-2875-13-91","article-title":"Correlation of biomarkers for parasite burden and immune activation with acute kidney injury in severe falciparum malaria","volume":"13","author":"Plewes","year":"2014","journal-title":"Malar J"},{"key":"10.1016\/j.idc.2018.10.002_bib61","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1186\/s12879-017-2373-1","article-title":"Cell-free hemoglobin mediated oxidative stress is associated with acute kidney injury and renal replacement therapy in severe falciparum malaria: an observational study","volume":"17","author":"Plewes","year":"2017","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.idc.2018.10.002_bib62","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/s41426-018-0105-2","article-title":"Intravascular hemolysis in severe Plasmodium knowlesi malaria: association with endothelial activation, microvascular dysfunction, and acute kidney injury","volume":"7","author":"Barber","year":"2018","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.idc.2018.10.002_bib63","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1093\/clind\/15.5.874","article-title":"Acute renal failure in patients with severe falciparum malaria","volume":"15","author":"Tran","year":"1992","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2018.10.002_bib64","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/1475-2875-10-217","article-title":"Laboratory prediction of the requirement for renal replacement in acute falciparum malaria","volume":"10","author":"Hanson","year":"2011","journal-title":"Malar J"},{"key":"10.1016\/j.idc.2018.10.002_bib65","doi-asserted-by":"crossref","first-page":"431","DOI":"10.3747\/pdi.2012.00118","article-title":"Peritoneal dialysis in children with acute kidney injury: a developing country experience","volume":"32","author":"Mishra","year":"2012","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.idc.2018.10.002_bib66","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1056\/NEJMoa020074","article-title":"Hemofiltration and peritoneal dialysis in infection-associated acute renal failure in Vietnam","volume":"347","author":"Phu","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.idc.2018.10.002_bib67","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1093\/ckj\/sfv112","article-title":"Haemodialysis for paediatric acute kidney injury in a low resource setting: experience from a tertiary hospital in South West Nigeria","volume":"9","author":"Asinobi","year":"2016","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.idc.2018.10.002_bib68","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1136\/bmj.38902.605347.7C","article-title":"Meta-analysis of frusemide to prevent or treat acute renal failure","volume":"333","author":"Ho","year":"2006","journal-title":"Br Med J"},{"key":"10.1016\/j.idc.2018.10.002_bib69","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1097\/00003246-200108000-00005","article-title":"Use of dopamine in acute renal failure: a meta-analysis","volume":"29","author":"Kellum","year":"2001","journal-title":"Crit Care Med"},{"key":"10.1016\/j.idc.2018.10.002_bib70","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1073\/pnas.0910174107","article-title":"Acetaminophen inhibits hemoprotein-catalyzed lipid peroxidation and attenuates rhabdomyolysis-induced renal failure","volume":"107","author":"Boutaud","year":"2010","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"7","key":"10.1016\/j.idc.2018.10.002_bib71","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1093\/cid\/ciy213","article-title":"Acetaminophen as a renoprotective adjunctive treatment in patients with severe and moderately severe falciparum malaria: a randomized, controlled, open-label trial","volume":"67","author":"Plewes","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2018.10.002_bib72","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12936-018-2195-7","article-title":"Adjunctive therapy for severe malaria: a review and critical appraisal","volume":"17","author":"Varo","year":"2018","journal-title":"Malar J"},{"key":"10.1016\/j.idc.2018.10.002_bib73","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(03)15162-8","article-title":"Artesunate combinations for treatment of malaria: meta-analysis","volume":"363","author":"Adjuik","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.idc.2018.10.002_bib74","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1128\/AAC.05756-11","article-title":"Population pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated malaria","volume":"56","author":"Tarning","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.idc.2018.10.002_bib75","doi-asserted-by":"crossref","first-page":"e1001564","DOI":"10.1371\/journal.pmed.1001564","article-title":"The effect of dosing regimens on the antimalarial efficacy of dihydroartemisinin-piperaquine: a pooled analysis of individual patient data","volume":"10","year":"2013","journal-title":"PLoS Med"},{"issue":"8","key":"10.1016\/j.idc.2018.10.002_bib76","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S1473-3099(18)30297-4","article-title":"Risk of sudden unexplained death after use of dihydroartemisinin\u2013piperaquine for malaria: a systematic review and Bayesian meta-analysis","volume":"18","author":"Chan","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.idc.2018.10.002_bib77","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/S1473-3099(12)70064-6","article-title":"Poor-quality antimalarial drugs in southeast Asia and sub-Saharan Africa","volume":"12","author":"Nayyar","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.idc.2018.10.002_bib78","doi-asserted-by":"crossref","first-page":"e1002290","DOI":"10.1371\/journal.pmed.1002290","article-title":"First-trimester artemisinin derivatives and quinine treatments and the risk of adverse pregnancy outcomes in Africa and Asia: a meta-analysis of observational studies","volume":"14","author":"Dellicour","year":"2017","journal-title":"PLoS Med"},{"key":"10.1016\/j.idc.2018.10.002_bib79","unstructured":"World Health Organization Global Malaria Programme. Single dose primaquine as\u00a0a gametocytocide in Plasmodium falciparum malaria. Available at: http:\/\/www.who.int\/malaria\/publications\/atoz\/who_pq_policy_recommendation\/en\/. Accessed December 20, 2012."},{"key":"10.1016\/j.idc.2018.10.002_bib80","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.pt.2016.09.002","article-title":"The treatment of Plasmodium knowlesi malaria","volume":"33","author":"Barber","year":"2017","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.idc.2018.10.002_bib81","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/cid\/cix779","article-title":"Artemether-lumefantrine versus chloroquine for the treatment of uncomplicated Plasmodium knowlesi malaria: an open-label randomized controlled trial CAN KNOW","volume":"66","author":"Grigg","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2018.10.002_bib82","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S1473-3099(15)00415-6","article-title":"Artesunate-mefloquine versus chloroquine for treatment of uncomplicated Plasmodium knowlesi malaria in Malaysia (ACT KNOW): an open-label, randomised controlled trial","volume":"16","author":"Grigg","year":"2016","journal-title":"Lancet Infect Dis"},{"issue":"10","key":"10.1016\/j.idc.2018.10.002_bib83","article-title":"Artemisinin-based combination therapy for treating uncomplicated Plasmodium vivax malaria","author":"Gogtay","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"10.1016\/j.idc.2018.10.002_bib84","article-title":"Primaquine for preventing relapse in people with Plasmodium vivax malaria treated with chloroquine","author":"Galappaththy","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.idc.2018.10.002_bib85","doi-asserted-by":"crossref","first-page":"e1002224","DOI":"10.1371\/journal.pmed.1002224","article-title":"Haemolysis in G6PD heterozygous females treated with primaquine for Plasmodium vivax malaria: a nested cohort in a trial of radical curative regimens","volume":"14","author":"Chu","year":"2017","journal-title":"PLoS Med"},{"key":"10.1016\/j.idc.2018.10.002_bib86","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0140-6736(13)62568-4","article-title":"Tafenoquine plus chloroquine for the treatment and relapse prevention of Plasmodium vivax malaria (DETECTIVE): a multicentre, double-blind, randomised, phase 2b dose-selection study","volume":"383","author":"Llanos-Cuentas","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.idc.2018.10.002_bib87","doi-asserted-by":"crossref","first-page":"e0006440","DOI":"10.1371\/journal.pntd.0006440","article-title":"Implications of current therapeutic restrictions for primaquine and tafenoquine in the radical cure of vivax malaria","volume":"12","author":"Watson","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.idc.2018.10.002_bib88","doi-asserted-by":"crossref","first-page":"771","DOI":"10.3201\/eid1705.101229","article-title":"Intravenous artesunate for severe malaria in travelers, Europe","volume":"17","author":"Zoller","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.idc.2018.10.002_bib89","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1182\/blood-2014-02-555953","article-title":"Postartesunate delayed hemolysis is a predictable event related to the lifesaving effect of artemisinins","volume":"124","author":"Jaureguiberry","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.idc.2018.10.002_bib90","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/scitranslmed.aaf9377","article-title":"Measuring the Plasmodium falciparum HRP2 protein in blood from artesunate-treated malaria patients predicts post-artesunate delayed hemolysis","volume":"9","author":"Ndour","year":"2017","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.idc.2018.10.002_bib91","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1186\/s12879-017-2678-0","article-title":"Post-treatment haemolysis in African children with hyperparasitaemic falciparum malaria; a randomized comparison of artesunate and quinine","volume":"17","author":"Fanello","year":"2017","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.idc.2018.10.002_bib92","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/cid\/ciw710","article-title":"High rate of treatment failures in nonimmune travelers treated with artemether-lumefantrine for uncomplicated plasmodium falciparum malaria in Sweden: retrospective comparative analysis of effectiveness and case series","volume":"64","author":"Sonden","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2018.10.002_bib93","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1128\/JCM.43.2.978-981.2005","article-title":"Diagnostic and therapeutic pitfalls associated with primaquine-tolerant Plasmodium vivax","volume":"43","author":"Spudick","year":"2005","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.idc.2018.10.002_bib94","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/1475-2875-11-245","article-title":"Plasmodium vivax malaria relapses at a travel medicine centre in Rio de Janeiro, a non-endemic area in Brazil","volume":"11","author":"Pedro","year":"2012","journal-title":"Malar J"},{"key":"10.1016\/j.idc.2018.10.002_bib95","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2016.03.011","article-title":"Primaquine pharmacology in the context of CYP 2D6 pharmacogenomics: current state of the art","volume":"161","author":"Marcsisin","year":"2016","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.idc.2018.10.002_bib96","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s12936-016-1145-5","article-title":"Tafenoquine treatment of Plasmodium vivax malaria: suggestive evidence that CYP2D6 reduced metabolism is not associated with relapse in the Phase 2b DETECTIVE trial","volume":"15","author":"St Jean","year":"2016","journal-title":"Malar J"},{"key":"10.1016\/j.idc.2018.10.002_bib97","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.pt.2017.01.004","article-title":"How to contain artemisinin- and multidrug-resistant falciparum malaria","volume":"33","author":"Dondorp","year":"2017","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.idc.2018.10.002_bib98","unstructured":"World Health Organization Global Malaria Programme. Artemisinin and artemisinin-based combination therapy resistance - Status Report. 2017. Available at: http:\/\/www.who.int\/malaria\/publications\/atoz\/artemisinin-resistance-april2017\/en\/. Accessed February 1, 2018."},{"key":"10.1016\/j.idc.2018.10.002_bib99","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/S1473-3099(14)70855-2","article-title":"Global extent of chloroquine-resistant Plasmodium vivax: a systematic review and meta-analysis","volume":"14","author":"Price","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.idc.2018.10.002_bib100","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1016\/S0140-6736(18)30792-X","article-title":"Effect of generalised access to early diagnosis and treatment and targeted mass drug administration on Plasmodium falciparum malaria in Eastern Myanmar: an observational study of a regional elimination programme","volume":"391","author":"Landier","year":"2018","journal-title":"Lancet"}],"container-title":["Infectious Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552018300898?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552018300898?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:16:58Z","timestamp":1760195818000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0891552018300898"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":100,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S0891552018300898"],"URL":"https:\/\/doi.org\/10.1016\/j.idc.2018.10.002","relation":{},"ISSN":["0891-5520"],"issn-type":[{"value":"0891-5520","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Malaria","name":"articletitle","label":"Article Title"},{"value":"Infectious Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idc.2018.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}